Today, Chris covers Gilead’s remdesevir pricing, the winners in a cashless society, and how PG&E will emerge from bankruptcy.
Topics discussed:
Links mentioned in this episode:
Chris rounds up the business news at Invstr to keep our community in the know. He prefers pancakes to waffles, micro-cap stocks to blue chips. A stock picker on the side, big up the Chris.
View episodesGet new episodes of Invstr Crunch automatically
